Loading...
Harrow Health reported a strong start to 2022, marking its seventh consecutive quarter of record financial results. The company saw a 43% increase in year-over-year revenues and a nearly 10% increase from the sequential quarter.
Achieved seventh consecutive quarter of record financial results.
Experienced a 43% increase in year-over-year revenues.
Saw a nearly 10% increase from the sequential quarter.
Anticipates potential commercial launch of AMP-100 in the first half of 2023, pending FDA approval.
Harrow Health is confident in its future growth plan, aiming to build a profitable business and serve customers with its products and services.